All HEI'sATU DonegalATU Galway-MayoATU SligoDublin City UniversityDun Laoghaire IADTDundalk ITMaynooth UniversityMTU CorkMTU KerryNational College of Ireland (NCI)NCADRoyal College of SurgeonsSETU CarlowSETU WaterfordTeagascTrinity College DublinTUD BlanchardstownTUD GrangegormonTUD TallaghtTUS AthloneTUS LimerickUniversity College CorkUniversity College DublinUniversity of GalwayUniversity of Limerick All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsGalMAX – A Cell Engineering StrategyGalMAX is a simple, rapid, and robust cell engineering strategy that maximises Galactosylation by simultaneously eliminating metabolic and cellular Machinery bottlenecks pdf 383.1KBA New Power Amplifier for Next Generation Wireless Communication Gallium Nitride power amplifiers are one of the key driving technologies enabling the next generation of wireless communication networks. Existing power amplifier architectures deliver efficient operation but only do so ... pdf 325KBNovel Diagnostic Test for TuberculosisBovine Tuberculosis remains an endemic in many countries despite the implementation of stringent surveillance and control programs. Current tests for BTB are limited in their ability for early and accurate diagnosis. Del... pdf 302.3KBRapid Acting Pharmaceutical for Infectious Disease (RAPID)Sepsis is a major challenge in the intensive care unit, where it is one of the leading causes of death. It arises unpredictability and can progress rapidly. Cilengitide, a potent inhibitor prevents bacterial binding to ... pdf 332.2KBHighly Selective Inhibitors of HDAC6 for the Treatment of Cancers and Neurodegenerative DiseaseA novel structural class of highly-selective HDAC6 inhibitors. These patented small molecules have a unique non-hydroxamic acid chemical structure. The lead compound BAS-2 has been shown to inhibit glycolysis in triple ... pdf 463.4KB First 12345678910111213141516171819202122 Last Print Bookmark Top